Correlation Between Tempest Therapeutics and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Virax Biolabs Group, you can compare the effects of market volatilities on Tempest Therapeutics and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Virax Biolabs.
Diversification Opportunities for Tempest Therapeutics and Virax Biolabs
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tempest and Virax is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Virax Biolabs go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Virax Biolabs
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Tempest Therapeutics is 2.27 times less risky than Virax Biolabs. The stock trades about -0.06 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 222.00 in Virax Biolabs Group on August 24, 2024 and sell it today you would lose (28.00) from holding Virax Biolabs Group or give up 12.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Virax Biolabs Group
Performance |
| Timeline |
| Tempest Therapeutics |
| Virax Biolabs Group |
Tempest Therapeutics and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Virax Biolabs
The main advantage of trading using opposite Tempest Therapeutics and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |